Skip to main content
    W

    Whitehawk Therapeutics, Inc. (WHWK)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.08
    +0.07 (+2.33%)

    Market Cap: $177.62M

    Last updated: Nov 17, 2026 at 4:11 PM ET

    Whitehawk Therapeutics, Inc. (WHWK) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Whitehawk Therapeutics (WHWK) has a market cap of $177.62M and an enterprise value of $108.64M. Its share count is up 35.64% from a year earlier. Revenue fell 100.00% over the last 12 months from the 12 months before.

    Total Valuation

    Enterprise value is 38.83% below the market cap, as cash exceeds debt.

    Market Cap$177.62M
    Enterprise Value$108.64M
    Latest price (Nov 17, 2026)$3.08

    Key Dates

    The next earnings report is expected on Mar 10, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 10, 2027 (expected)
    Last Earnings DateNov 9, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 13.25% in the quarter ended Sep 30, 2026 and grew 86.31% a year over 2 years.

    Shares Outstanding93.87M
    Shares Change (YoY)+35.64%
    Shares Change (QoQ)+13.25%
    Share Count Growth (2Y CAGR)+86.31%

    Price Statistics

    The stock is up 43.93% over 52 weeks and trades 11.49% below its 50-day average.

    Beta (1Y)1.49
    52-Week Change+43.93%
    1-Month Change+2.33%
    3-Month Change-36.76%
    6-Month Change-24.32%
    5-Year Change-88.00%
    Total Return (1Y)+43.93%
    Total Return (3Y CAGR)-13.20%
    Total Return (5Y CAGR)-33.40%
    Return vs SPY (1Y)+32.37%
    Max Drawdown (1Y)-43.33%
    Max Drawdown (3Y)-75.60%
    Sharpe Ratio (1Y)0.54
    Correlation with SPY (1Y)0.30
    50-Day Average$3.48
    200-Day Average$3.86
    52-Week Range$1.97 to $5.50
    RSI (14 Days)43.8
    Average Volume (20 Days)377.12K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 16.47x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio16.47x
    Quick Ratio16.47x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -51.05% over the last 12 months, against a 5-year average of -63.58%.

    Return on Equity (ROE)-51.05%
    Return on Assets (ROA)-47.96%
    ROE (5Y Average)-63.58%
    ROA (5Y Average)-51.29%
    ROIC (5Y Average)-15.55%

    Scores

    WHWK has a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.

    Piotroski F-Score3 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Revenue Growth (YoY)-100.00%
    Gross Profit-$1.00K
    Operating Income-$89.46M
    Pretax Income-$83.29M
    Net Income-$83.29M
    Reported EPS (TTM)-$1.09

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 93.94% of the $173.69M in total assets.

    Cash and Equivalents$68.97M
    Total Debt$0
    Net Cash$68.97M
    Net Cash Per Share$0.73
    Working Capital$161.53M
    Shareholder Equity$163.16M
    Book Value Per Share$1.74
    Total Assets$173.69M
    Total Liabilities$10.53M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$73.64M
    FCF Per Share-$1.29
    Depreciation and Amortization$1.88M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Growth

    Revenue fell 22.27% a year over 3 years.

    Revenue Growth (3Y CAGR)-22.27%
    Revenue Growth (5Y CAGR)-13.29%
    Book Value Per Share Growth (2Y CAGR)-28.95%
    Tangible Book Per Share Growth (2Y CAGR)-28.95%

    Revenue and profit by year

    Dividends and Yields

    WHWK does not pay a dividend.

    Buyback Yield-28.27%
    Shareholder Yield-28.27%

    Stock Splits

    The last split was a 1-for-15 reverse split on Aug 27, 2021.

    Last Split DateAug 27, 2021
    Split TypeReverse split
    Split Ratio1:15

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About WHWK

    What is WHWK's market cap?

    Whitehawk Therapeutics has a market cap of $177.62M. Its enterprise value, which adds debt and subtracts cash, is $108.64M.

    How many shares of WHWK are outstanding?

    Whitehawk Therapeutics has 93.87M shares outstanding. The count is up 35.64% from a year earlier.

    Does WHWK pay a dividend?

    No. Whitehawk Therapeutics does not pay a dividend.

    How much debt does WHWK have?

    Whitehawk Therapeutics has $0 of total debt and $68.97M of cash and equivalents, a net cash position of $68.97M.